MGWM
RMD icon

Marks Group Wealth Management’s ResMed RMD Stock Holding History

Marks Group Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.12M Sell
27,242
-3,397
-11% -$847K 0.59% 63
2025
Q4 		$7.38M Sell
30,639
-3,659
-11% -$936K 0.71% 46
2025
Q3 		$9.39M Sell
34,298
-1,696
-5% -$463K 0.87% 29
2025
Q2 		$9.29M Sell
35,994
-2,037
-5% -$486K 0.86% 35
2025
Q1 		$8.51M Buy
+38,031
New +$8.88M 0.82% 49

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marks Group Wealth Management's RMD Position: Q1 2026 in Review

Marks Group Wealth Management reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $847K and leaving 27,242 shares worth $6.12M. The position accounts for 0.59% of the portfolio, ranked #63.

Marks Group Wealth Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.39M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Marks Group Wealth Management held 27,242 shares of ResMed worth $6.12M as of Q1 2026.
  • Marks Group Wealth Management sold 3,397 ResMed shares in Q1 2026, an estimated $847K.
  • ResMed made up 0.59% of Marks Group Wealth Management's portfolio in Q1 2026, its #63 holding.
  • Marks Group Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • Marks Group Wealth Management's ResMed position peaked at $9.39M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Marks Group Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.